{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:40Z","timestamp":1760028520093,"version":"build-2065373602"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94219","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:58:17Z","timestamp":1760025497000},"source":"Crossref","is-referenced-by-count":0,"title":["King Kong Pox: A Case of Severe Mpox and Bartonella Co-infection in a Patient Living With Human Immunodeficiency Virus (HIV)"],"prefix":"10.7759","author":[{"given":"Anurag","family":"Karki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashirbad","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puja","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220415120","article-title":"Virulence differences of Mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model","volume":"120","author":"Americo JL","year":"2023","unstructured":"Americo JL, Earl PL, Moss B. Virulence differences of Mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci U S A. 2023, 120:e2220415120. 10.1073\/pnas.2220415120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(03)00856-9","article-title":"Human monkeypox: an emerging zoonosis","volume":"4","author":"Di Giulio DB","year":"2004","unstructured":"Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004, 4:15-25. 10.1016\/s1473-3099(03)00856-9","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study","volume":"400","author":"Tar\u00edn-Vicente EJ","year":"2022","unstructured":"Tar\u00edn-Vicente EJ, Alemany A, Agud-Dios M, et al.. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022, 400:661-9. 10.1016\/S0140-6736(22)01436-2","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill JP","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, et al.. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022, 387:679-91. 10.1056\/NEJMoa2207323","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: a global case series","volume":"401","author":"Mitj\u00e0 O","year":"2023","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, et al.. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023, 401:939-49. 10.1016\/S0140-6736(23)00273-8","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad052","article-title":"Severe Mpox infections in people with uncontrolled human immunodeficiency virus","volume":"76","author":"Govind A","year":"2023","unstructured":"Govind A, Lazarte SM, Kitchell E, et al.. Severe Mpox infections in people with uncontrolled human immunodeficiency virus. Clin Infect Dis. 2023, 76:1843-6. 10.1093\/cid\/ciad052","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report","volume":"19","author":"Yinka-Ogunleye A","year":"2019","unstructured":"Yinka-Ogunleye A, Aruna O, Dalhat M, et al.. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019, 19:872-9. 10.1016\/S1473-3099(19)30294-4","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13622","article-title":"The effect of HIV and Mpox co-infection on clinical outcomes: systematic review and meta-analysis","volume":"25","author":"Taha AM","year":"2024","unstructured":"Taha AM, Elrosasy A, Mahmoud AM, et al.. The effect of HIV and Mpox co-infection on clinical outcomes: systematic review and meta-analysis. HIV Med. 2024, 25:897-909. 10.1111\/hiv.13622","journal-title":"HIV Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum FM","year":"2022","unstructured":"Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, R\u00e9nia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022, 22:597-613. 10.1038\/s41577-022-00775-4","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3201\/eid2909.230469","article-title":"Pharyngeal co-infections with monkeypox virus and group A Streptococcus, United States, 2022","volume":"29","author":"Kaiser RM","year":"2023","unstructured":"Kaiser RM, Cash-Goldwasser S, Lehnertz N, et al.. Pharyngeal co-infections with monkeypox virus and group A Streptococcus, United States, 2022. Emerg Infect Dis. 2023, 29:1855-8. 10.3201\/eid2909.230469","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of human monkeypox in Nigeria","volume":"71","author":"Ogoina D","year":"2020","unstructured":"Ogoina D, Iroezindu M, James HI, et al.. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis. 2020, 71:e210-4. 10.1093\/cid\/ciaa143","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7132e4","article-title":"Interim guidance for prevention and treatment of monkeypox in persons with HIV infection - United States, August 2022","volume":"71","author":"O'Shea J","year":"2022","unstructured":"O'Shea J, Filardo TD, Morris SB, Weiser J, Petersen B, Brooks JT. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection - United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:1023-8. 10.15585\/mmwr.mm7132e4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02075-X","article-title":"Monkeypox","volume":"401","author":"Mitj\u00e0 O","year":"2023","unstructured":"Mitj\u00e0 O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, Orkin CM. Monkeypox. Lancet. 2023, 401:60-74. 10.1016\/S0140-6736(22)02075-X","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-013126","article-title":"Mpox (monkeypox) risk and mortality associated with HIV infection: a national case-control study in Nigeria","volume":"8","author":"Yinka-Ogunleye A","year":"2023","unstructured":"Yinka-Ogunleye A, Dalhat M, Akinpelu A, et al.. Mpox (monkeypox) risk and mortality associated with HIV infection: a national case-control study in Nigeria. BMJ Glob Health. 2023, 8:e013126. 10.1136\/bmjgh-2023-013126","journal-title":"BMJ Glob Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad505","article-title":"Associations between HIV and severe Mpox in an Atlanta cohort","volume":"229","author":"Aldred B","year":"2024","unstructured":"Aldred B, Scott JY, Aldredge A, et al.. Associations between HIV and severe Mpox in an Atlanta cohort. J Infect Dis. 2024, 229:S234-42. 10.1093\/infdis\/jiad505","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/230396","article-title":"Bacillary angiomatosis in an HIV-positive man with multiple risk factors: a clinical and epidemiological puzzle","volume":"16","author":"Mateen FJ","year":"2005","unstructured":"Mateen FJ, Newstead JC, McClean KL. Bacillary angiomatosis in an HIV-positive man with multiple risk factors: a clinical and epidemiological puzzle. Can J Infect Dis Med Microbiol. 2005, 16:249-52. 10.1155\/2005\/230396","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02049-0","article-title":"Tecovirimat for the treatment of severe Mpox in Germany","volume":"51","author":"Hermanussen L","year":"2023","unstructured":"Hermanussen L, Brehm TT, Wolf T, et al.. Tecovirimat for the treatment of severe Mpox in Germany. Infection. 2023, 51:1563-8. 10.1007\/s15010-023-02049-0","journal-title":"Infection"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7137e1","article-title":"Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol - United States, May-August 2022","volume":"71","author":"O'Laughlin K","year":"2022","unstructured":"O'Laughlin K, Tobolowsky FA, Elmor R, et al.. Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol - United States, May-August 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:1190-5. 10.15585\/mmwr.mm7137e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/M22-3132","article-title":"Tecovirimat treatment of people with HIV during the 2022 Mpox outbreak: a retrospective cohort study","volume":"176","author":"McLean J","year":"2023","unstructured":"McLean J, Stoeckle K, Huang S, Berardi J, Gray B, Glesby MJ, Zucker J. Tecovirimat treatment of people with HIV during the 2022 Mpox outbreak: a retrospective cohort study. Ann Intern Med. 2023, 176:642-8. 10.7326\/M22-3132","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00762-07","article-title":"Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses","volume":"51","author":"Quenelle DC","year":"2007","unstructured":"Quenelle DC, Prichard MN, Keith KA, et al.. Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses. Antimicrob Agents Chemother. 2007, 51:4118-24. 10.1128\/AAC.00762-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-023-00682-w","article-title":"Mpox and HIV-collision of two diseases","volume":"20","author":"Zucker J","year":"2023","unstructured":"Zucker J, Hazra A, Titanji BK. Mpox and HIV-collision of two diseases. Curr HIV\/AIDS Rep. 2023, 20:440-50. 10.1007\/s11904-023-00682-w","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-023-00661-1","article-title":"Mpox and HIV: a narrative review","volume":"20","author":"Saldana CS","year":"2023","unstructured":"Saldana CS, Kelley CF, Aldred BM, Cantos VD. Mpox and HIV: a narrative review. Curr HIV\/AIDS Rep. 2023, 20:261-9. 10.1007\/s11904-023-00661-1","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395816-king-kong-pox-a-case-of-severe-mpox-and-bartonella-co-infection-in-a-patient-living-with-human-immunodeficiency-virus-hiv","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:58:18Z","timestamp":1760025498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395816-king-kong-pox-a-case-of-severe-mpox-and-bartonella-co-infection-in-a-patient-living-with-human-immunodeficiency-virus-hiv"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.94219","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}